ERAS

13.6104.29%
AW

Alexander Whitman Casdin

Independent Director

Mr. Alexander Whitman Casdin, also known as Alex, is a Director at Project Sage Oldco, Inc. (formerly known as Sientra, Inc.) since June 15, 2023. He has been the Chief Financial Officer at Epirium Bio, Inc. since October 2020 and serves as its Chief Operating Officer and serves as its Chief Executive Officer since January 01, 2025 and also serves as its Director and he has also served as the Chief Operating Officer of Epirium since November 2021. Prior to joining Epirium, Mr. Casdin was founder, CEO and portfolio manager of Reneo Capital Management LP from January 2015 to October 2020. He serves as Independent Director of Erasca, Inc. since July 2018. He has been a member of the board of directors of multiple life science companies, including DiaVacs and serves on the advisory board for LunaDNA. He served as an Executive Advisor of Ignyta, Inc., since December 2012 and served as its Director since October 31, 2013 until February 8, 2018. From September 2012 through December 2014, Mr. Casdin was a private investor focused on the healthcare sector. Mr. Casdin served as the Chief Financial Officer at Sophiris Bio, Inc. from October 10, 2011 to September 14, 2012. He served as Vice President, Finance of Amylin Pharmaceuticals, from October 2009 to October 2011, overseeing Financial Planning and Analysis, Investor Relations and Treasury. He joined it in 2009. Prior to founding Casdin Advisors in 2008, Mr. Casdin served as the Chief Executive Officer, Partner and Portfolio Manager at Cooper Hill Partners, L.L.C. and joined it in September 2001. He served as the Chief Executive Officer of Cooper Hill Partners. Mr. Casdin was a Founder and Strategic Advisor to the Life Sciences industry at Casdin Advisors LLC. He was employed by Pequot Capital Management Inc. He joined Pequot in March 1999. He served at the Dreyfus Corporation as a Health Care Analyst covering all areas of health care including pharmaceuticals, biotechnology and medical device companies. He served as Director of Receptor Holdings, Inc. since April 2019. Mr. Casdin has served as a Legislative Assistant to Congressman Robert J. Mrazek (D-N.Y.) and then as a Legislative Affairs Specialist for Patton Boggs LLP. He serves as a Member of the Advisory Board of Mountain Group Capital LLC and the Social Enterprise Program at Columbia Business School. He served as a Director of DUSA Pharmaceuticals Inc. since January 29, 2009 until December 20, 2012. Mr. Casdin holds an M.B.A., from Columbia Business School in 1996. He holds B.A. in Political Science from Brown University. He served as Member of Advisory Board at Rosalind Scientific LLC until 2024.

公司職務